Cargando…

Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism

Diabetic cardiomyopathy (DCM) is one of the many complications of diabetes. DCM leads to cardiac insufficiency and myocardial remodeling and is the main cause of death in diabetic patients. Abnormal lipid metabolism plays an important role in the occurrence and development of DCM. Huangqi Shengmai Y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Zhanhong, Pan, Jianheng, Sui, Xin, Fang, Chunqiu, Li, Na, Huang, Xiaowei, Qu, Xiaobo, Han, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238573/ https://www.ncbi.nlm.nih.gov/pubmed/34249132 http://dx.doi.org/10.1155/2021/5590623

Ejemplares similares

Huangqi Shengmai Yin Ameliorates Myocardial Fibrosis by Activating Sirtuin3 and Inhibiting TGF-β/Smad Pathway
por: Pan, Jianheng, et al.
Publicado: (2021)

Huangqi Shengmai Yin Protects against Radiation-Induced Cardiac Fibrosis Injury by Regulating the TGF-β1/Smads and MMPs
por: Gu, Jing, et al.
Publicado: (2019)

Shengmai Yin formula modulates the gut microbiota of spleen-deficiency rats
por: You, Yu, et al.
Publicado: (2020)

Effect of Shengmai Yin on Epithelial-Mesenchymal Transition of Nasopharyngeal Carcinoma Radioresistant Cells
por: Wang, Ze-tai, et al.
Publicado: (2022)

Exploring the mechanism of Shengmai Yin for coronary heart disease based on systematic pharmacology and chemoinformatics
por: Jiang, Yan, et al.
Publicado: (2020)

Interaction between Warfarin and the Herbal Product Shengmai-Yin: A Case Report of Intracerebral Hematoma
por: Su, Qun, et al.
Publicado: (2010)

Effect of Shengmai Yin on the DNA methylation status of nasopharyngeal carcinoma cell and its radioresistant strains
por: Liu, Shiya, et al.
Publicado: (2021)

A Metabolomic Study of Rats with Doxorubicin-Induced Cardiomyopathy and Shengmai Injection Treatment
por: Chen, Yu, et al.
Publicado: (2015)

Shengmai Injection Improved Doxorubicin-Induced Cardiomyopathy by Alleviating Myocardial Endoplasmic Reticulum Stress and Caspase-12 Dependent Apoptosis
por: Chen, Yu, et al.
Publicado: (2015)

Shengmai San Ameliorates Myocardial Dysfunction and Fibrosis in Diabetic db/db Mice
por: Zhao, Juan, et al.
Publicado: (2016)

Use of a Systematic Pharmacological Methodology to Explore the Mechanism of Shengmai Powder in Treating Diabetic Cardiomyopathy
por: Zhang, Shi-ying, et al.
Publicado: (2020)

In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity
por: Zhou, Peng, et al.
Publicado: (2022)

The Inhibition of the Components from Shengmai Injection towards UDP-Glucuronosyltransferase
por: Jiang, Li-Peng, et al.
Publicado: (2014)

The Protective Effects of Shengmai Formula Against Myocardial Injury Induced by Ultrafine Particulate Matter Exposure and Myocardial Ischemia are Mediated by the PI3K/AKT/p38 MAPK/Nrf2 Pathway
por: Chen, Lina, et al.
Publicado: (2021)

Investigation of the Mechanism of Shengmai Injection on Sepsis by Network Pharmacology Approaches
por: Lu, Juan, et al.
Publicado: (2020)

Membrane Lipids and CFTR: The Yin/Yang of Efficient Ceramide Metabolism
por: Bonfield, Tracey L.
Publicado: (2020)

Contribution of Increased Expression of Yin Yang 2 to Development of Cardiomyopathy
por: Zhang, Yi, et al.
Publicado: (2020)

The Protective Role of Yin‐Yang 1 in Cardiac Injury and Remodeling After Myocardial Infarction
por: Huang, Yu, et al.
Publicado: (2021)

The Protective Effect of Sheng Mai Yin on Diabetic Cardiomyopathy via NLRP3/Caspase-1 Pathway
por: Li, Jing-Ya, et al.
Publicado: (2022)

The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials
por: Yu, Liuqin, et al.
Publicado: (2018)

Protective capability of Astragalus (Huangqi) on auditory function in a rat model of estrogen deficiency
por: Hu, Xu-Jun
Publicado: (2019)

Huangqi-Danshen decoction protects against cisplatin-induced acute kidney injury in mice
por: Liu, Xinhui, et al.
Publicado: (2023)

Yin and Yang of NADPH Oxidases in Myocardial Ischemia-Reperfusion
por: Matsushima, Shouji, et al.
Publicado: (2022)

Panax notoginseng Saponin Protects Against Diabetic Cardiomyopathy Through Lipid Metabolism Modulation
por: Zhang, Chenyang, et al.
Publicado: (2022)

Shengmai injection inhibits palmitic acid-induced myocardial cell inflammatory death via regulating NLRP3 inflammasome activation
por: Yin, Gang, et al.
Publicado: (2023)

Traditional Chinese Medicine Formulation Huangqi Jianzhong Tang Improves Cardiac Function after Myocardial Infarction in Rats
por: Bao, Ya-Ru, et al.
Publicado: (2020)

Yin Yang 1 Regulates the Transcriptional Activity of Androgen Receptor
por: Deng, Zhiyong, et al.
Publicado: (2009)

Meta-Analysis of the Clinical Value of Danshen Injection and Huangqi Injection in Liver Cirrhosis
por: Zhu, Changtai, et al.
Publicado: (2013)

Pharmacokinetic Compatibility of Ginsenosides and Schisandra Lignans in Shengmai-san: From the Perspective of P-Glycoprotein
por: Liang, Yan, et al.
Publicado: (2014)

The Efficacy of Hydroxychloroquine Combined with Huangqi Tablets in the Treatment of Diabetic Nephropathy
por: Chen, Xiaorong, et al.
Publicado: (2021)

Taking Diabetes to Heart—Deregulation of Myocardial Lipid Metabolism in Diabetic Cardiomyopathy
por: Bayeva, Marina, et al.
Publicado: (2013)

Bélver Yin /
por: Ferrero, Jesús, 1952-
Publicado: (1993)

The AMPK pathway in fatty liver disease
por: Fang, Chunqiu, et al.
Publicado: (2022)

Metabolomics Analysis Reveals the Protection Mechanism of Huangqi–Danshen Decoction on Adenine-Induced Chronic Kidney Disease in Rats
por: Liu, Xinhui, et al.
Publicado: (2019)

Cardioprotection by combination of three compounds from ShengMai preparations in mice with myocardial ischemia/reperfusion injury through AMPK activation-mediated mitochondrial fission
por: Li, Fang, et al.
Publicado: (2016)

Prediction the Molecular Mechanism of Shengmai Injection in Acute Treatment of COVID-19 Based on Network Pharmacology
por: Wang, Chen, et al.
Publicado: (2022)

Evaluation of Potential Herb-Drug Interactions Between Shengmai Injection and Losartan Potassium in Rat and In Vitro
por: Niu, Zhenchao, et al.
Publicado: (2022)

Effect of repeated Shengmai-San administration on nifedipine pharmacokinetics and the risk/benefit under co-treatment
por: Wang, Hong-Jaan, et al.
Publicado: (2022)

Network Pharmacology Analysis of Huangqi Jianzhong Tang Targets in Gastric Cancer
por: Li, Long, et al.
Publicado: (2022)

Retracted: The Efficacy of Hydroxychloroquine Combined with Huangqi Tablets in the Treatment of Diabetic Nephropathy
por: Engineering, Journal of Healthcare
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4iul97kfbbvhbk7omrooo5123s